Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study

Introduction and objectives: The use of neuromuscular blockers during surgery represented a landmark for anesthesiology. However, their use can prompt residual Neuromuscular Blockade (RNMB) and objective monitoring of neuromuscular function is crucial to warrant the recovery of muscle strength. The...

Full description

Bibliographic Details
Main Authors: Pedro Marcos Silva e Gonçalves, Alexandra de Vasconcelos Vieira, Claudia Helena Ribeiro da Silva, Renato Santiago Gomez
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Brazilian Journal of Anesthesiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0104001420302116
_version_ 1811227547103395840
author Pedro Marcos Silva e Gonçalves
Alexandra de Vasconcelos Vieira
Claudia Helena Ribeiro da Silva
Renato Santiago Gomez
author_facet Pedro Marcos Silva e Gonçalves
Alexandra de Vasconcelos Vieira
Claudia Helena Ribeiro da Silva
Renato Santiago Gomez
author_sort Pedro Marcos Silva e Gonçalves
collection DOAJ
description Introduction and objectives: The use of neuromuscular blockers during surgery represented a landmark for anesthesiology. However, their use can prompt residual Neuromuscular Blockade (RNMB) and objective monitoring of neuromuscular function is crucial to warrant the recovery of muscle strength. The present study aimed to estimate the incidence of RNMB and late Neuromuscular Blockade (LNMB) at the Post-Anesthetic Recovery Unit (PACU). Method: The study included 85 patients, 43 of which received cisatracurium and 42 of which, rocuronium. The depth of the Neuromuscular Blockade (NMB) was assessed by Train Of Four (TOF). NMB reversal was performed with the administration of neostigmine and atropine.RNMB was defined when a patient presented TOF below 90% at the PACU. Results: RNMB at the PACU was diagnosed in 39.5% and 40.5% of the patients receiving cisatracurium and rocuronium, respectively (p = 1.0). LNMB at the PACU was found in 32.6% and 16.7% of the patients receiving cisatracurium and rocuronium, respectively (p = 0.131). Conclusions: The incidence ofRNMB remains significant despite the use of intermediate-acting neuromuscular blockers and reversal agents. There was no statistically significant difference in the incidence of RNMB or LNMB in patients receiving cisatracurium or rocuronium. The use of objective NMB monitoring is effective for the diagnosis of RNMB, as well as for treatment management.
first_indexed 2024-04-12T09:44:26Z
format Article
id doaj.art-7624f29afc6f4662b252c8a00fa878ea
institution Directory Open Access Journal
issn 0104-0014
language English
last_indexed 2024-04-12T09:44:26Z
publishDate 2021-01-01
publisher Elsevier
record_format Article
series Brazilian Journal of Anesthesiology
spelling doaj.art-7624f29afc6f4662b252c8a00fa878ea2022-12-22T03:38:00ZengElsevierBrazilian Journal of Anesthesiology0104-00142021-01-017113843Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort studyPedro Marcos Silva e Gonçalves0Alexandra de Vasconcelos Vieira1Claudia Helena Ribeiro da Silva2Renato Santiago Gomez3Universidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Programa de Pós-Graduação em Ciências Aplicadas à Cirurgia e à Oftalmologia, Belo Horizonte, MG, Brasil; Corresponding author.Hospital Unimed BH – Unidade Contorno, Serviço de Anestesiologia, Belo Horizonte, MG, BrasilHospital Unimed BH – Unidade Contorno, Serviço de Anestesiologia, Belo Horizonte, MG, BrasilUniversidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Programa de Pós-Graduação em Ciências Aplicadas à Cirurgia e à Oftalmologia, Belo Horizonte, MG, BrasilIntroduction and objectives: The use of neuromuscular blockers during surgery represented a landmark for anesthesiology. However, their use can prompt residual Neuromuscular Blockade (RNMB) and objective monitoring of neuromuscular function is crucial to warrant the recovery of muscle strength. The present study aimed to estimate the incidence of RNMB and late Neuromuscular Blockade (LNMB) at the Post-Anesthetic Recovery Unit (PACU). Method: The study included 85 patients, 43 of which received cisatracurium and 42 of which, rocuronium. The depth of the Neuromuscular Blockade (NMB) was assessed by Train Of Four (TOF). NMB reversal was performed with the administration of neostigmine and atropine.RNMB was defined when a patient presented TOF below 90% at the PACU. Results: RNMB at the PACU was diagnosed in 39.5% and 40.5% of the patients receiving cisatracurium and rocuronium, respectively (p = 1.0). LNMB at the PACU was found in 32.6% and 16.7% of the patients receiving cisatracurium and rocuronium, respectively (p = 0.131). Conclusions: The incidence ofRNMB remains significant despite the use of intermediate-acting neuromuscular blockers and reversal agents. There was no statistically significant difference in the incidence of RNMB or LNMB in patients receiving cisatracurium or rocuronium. The use of objective NMB monitoring is effective for the diagnosis of RNMB, as well as for treatment management.http://www.sciencedirect.com/science/article/pii/S0104001420302116Neuromuscular blockersGeneral anesthesiaNeuromuscular monitoringNeostigmineRecovery unitPostoperative complications
spellingShingle Pedro Marcos Silva e Gonçalves
Alexandra de Vasconcelos Vieira
Claudia Helena Ribeiro da Silva
Renato Santiago Gomez
Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
Brazilian Journal of Anesthesiology
Neuromuscular blockers
General anesthesia
Neuromuscular monitoring
Neostigmine
Recovery unit
Postoperative complications
title Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
title_full Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
title_fullStr Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
title_full_unstemmed Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
title_short Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
title_sort residual neuromuscular blockade and late neuromuscular blockade at the post anesthetic recovery unit prospective cohort study
topic Neuromuscular blockers
General anesthesia
Neuromuscular monitoring
Neostigmine
Recovery unit
Postoperative complications
url http://www.sciencedirect.com/science/article/pii/S0104001420302116
work_keys_str_mv AT pedromarcossilvaegoncalves residualneuromuscularblockadeandlateneuromuscularblockadeatthepostanestheticrecoveryunitprospectivecohortstudy
AT alexandradevasconcelosvieira residualneuromuscularblockadeandlateneuromuscularblockadeatthepostanestheticrecoveryunitprospectivecohortstudy
AT claudiahelenaribeirodasilva residualneuromuscularblockadeandlateneuromuscularblockadeatthepostanestheticrecoveryunitprospectivecohortstudy
AT renatosantiagogomez residualneuromuscularblockadeandlateneuromuscularblockadeatthepostanestheticrecoveryunitprospectivecohortstudy